Homology Medicines Inc (NASDAQ:FIXX)

17.34
Delayed Data
As of Jan 17
 -0.27 / -1.53%
Today’s Change
11.05
Today|||52-Week Range
31.80
-16.23%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Homology Medicines Inc have a median target of 35.00, with a high estimate of 37.00 and a low estimate of 29.00. The median estimate represents a +101.85% increase from the last price of 17.34.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Homology Medicines Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.68
Sales
$1.5M
Reporting Date
Mar 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.74%
 
 
 
 
 
 
Growthannually -29.42%
 
 
 
 

Sales

Growthquarterly 244.67%
 
 
 
 
 
 
Growthannually -34.84%
 
 
 
 
Key to the earnings and sales forecast charts.